|
Month
|
Topics
|
No 277
December 2016
 |
- MHRA Drug Safety Update (December 2016)
- Duloxetine in stress urinary incontinence
- CAPC Technical Working Group
- Tafluprost / Timolol (Taptiqom)
- Safinamide (Xadago) (Not accepted for routine use)
- NICE Guidance
- NICE CG127 (Updated Nov '16): Hypertension in adults
- NICE TA 418 (Nov '16): Dapagliflozin in triple therapy for treating type 2 diabetes
- NICE TA 288 (Updated Nov '16): Dapagliflozin in combination therapy for treating type 2 diabetes
- NICE TA 419 (Nov '16): Apremilast for treating moderate to severe plaque psoriasis
- Multimorbidity and Managing Alice
- Wise words from Andrew Herxheimer
- Chronic pain
|
No. 276
November 2016 |
- MHRA Drug Safety Update (October 2016, November 2016)
- Sodium valproate
- Testing treatments
- Antimicrobial stewardship
- Sepsis toolkit
- COPD
- Significant event analysis
|
No. 275
September 2016 |
- MHRA Drug Safety Update (July 2016, September 2016)
- Polypharmacy
- NICE Guidance
- NICE CG140 (Aug '16): Palliative care for adults: strong opioids for pain relief
- NICE CG 44 (updated Aug '16) Heavy menstrual bleeding: assessment and management
- NICE NG17 (Updated Jul '16) Type 1 diabetes in adults
- NICE NG 28 (Updated Jul '16) Type 2 diabetes in adults
- NICE NG 56 (Sept '16) Multimorbidity: clinical assessment and management
- Shared decision making
- Choosing wisely
- Quality tip of the month - Midazolam
- Statins
- Opioid epidemic
|
No. 274
July 2016 |
- MHRA Drug Safety Update (June 2016)
- CAPC Technical Working Group
- Brivaracetam (Briviact)
- Aclidinium/Formoterol inhalation powder (Duaklir Genuair)
- Quality tip of the month - Drug name confusion resulting in large tablet quantity to be taken
- NICE Guidance
- NICE TA 390 (May '16): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
- NICE CG 42 (updated May '16) Dementia: supporting people with dementia and their carers in health and social care
- NICE CG 152 (Updated May '16) Crohn's disease: management
- NICE TA 393 (June '16) Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
- NICE TA 394 (June '16) Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
- Selling statins blog on BMJ website
- Asthma training course
|
No. 273
May 2016 |
- MHRA Drug Safety Update (April 2016)
- CAPC Technical Working Group
- Ivermectin 1% cream (Soolantra)
- Guanfacine (Intuniv)
- NICE Guidance
- NICE CG 90: Depression in adults: recognition and management
- NICE TA 388: Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction
- Opioids Aware
- Inhaled corticosteroids and pneumonia
- EBM and shared decision making
- Nefopam - Non formulary drug
|
No. 272
April 2016 |
- MHRA Drug Safety Update (February 2016, March 2016)
- CAPC Technical Working Group
- Liraglutide/insulin degludec (Xultophy)
- Dulaglutide (Trulicity)
- Lisdexamfetamine (Elvanse)
- Rifaximin (Targaxan)
- NICE Guidance
- NICE TA 385: Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia
- NICE e-learning
- Antimicrobial resistance animation
- Shared decision making video
- Bleeding risk with antidepressants and NSAIDs
|
No. 271
February 2016 |
- MHRA Drug Safety Update (December 2015, January 2016)
- NICE Guidance
- NICE TA 369: Ciclosporin for treating dry eye disease
- Antimicrobial resistance e-learning
- Opioids Aware
- Reboxetine
- High risk prescribing
- Cognitive psychology
|
